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LETTER TO THE EDITOR
DIFFERENTIAL DIAGNOSIS OF RESPIRATORY VIRUSES BY USING  
REAL TIME RT-PCR METHODOLOGY
São Paulo, August 8, 2013
Dear Editor
The emergence of new respiratory viruses including: the Severe 
Acute Respiratory Syndrome; the coronavirus in 2003 (SARS-CoV); 
influenza A(H1N1)pdm09, in the human population in the past ten 
years; the emergence of a new coronavirus identified in a patient 
presenting severe acute respiratory syndrome who travelled to 
Saudi Arabia (June, 2012), denominated as Middle East Respiratory 
Syndrome (MERS-CoV); and laboratory confirmation of three human 
infections with an avian influenza A(H7N9) virus not previously 
reported in humans on March 29, 2013, has encouraged scientists to 
develop diagnostic tests to identify these viruses1,2,3,4. The Adolfo Lutz, 
a Public Health Institute, has been improving its methodology tools 
in order to provide a timely answer to public health authorities facing 
acute respiratory disease outbreaks.
To apply the Centers for Disease Control and Prevention (CDC) 
Real Time RT-PCR as respiratory viruses’ differential diagnosis in 
clinical specimens, a total of 252 respiratory secretions were collected 
from patients presenting influenza-like syndrome by the three Brazilian 
National Influenza Surveillance Network - Sentinel Units: Hospital 
Menino Jesus; Hospital Vila Maria; Hospital Geral de Guarulhos; during 
influenza season 2010. These samples presented negative results for 
influenza virus A(H1N1), A(H1N1)pdm09, A(H3N2) and B strains by 
CDC rRT-PCR ; and were also proven negative by differential diagnosis 
by the use of respiratory monoclonal panel to investigate: influenza A 
and B viruses, respiratory syncytial virus, adenovirus and parainfluenza 
1, 2 and 3 viruses by Indirect Immunofluorescence (IFI). The differential 
diagnosis in samples presenting negative results, by both methodologies, 
was submitted to the CDC Real RT-PCR containing primers and probes 
for adenovirus (ADV), rhinovirus (RVs), respiratory syncytial virus 
(RSV), human metapneumovirus (hMPV ), parainfluenza 1, 2, 3, 
4(PV1, PV2,  PV3, PV4), kindly provided by Dr. Dean Erdman. Of the 
252 clinical specimens presenting negative results by using differential 
monoclonal respiratory panel IFI, 60 (23.80%) were positive by Real 
Time RT-PCR, the following etiologic agents have been identified: 
RSV 20 (33.40%); PV1 3 (5%); PV2 7 (11.60%); PV3 9 (15%) RVs 10 
(16.60%); ADV 11 (18.40%).
This study demonstrates the high sensitivity of Real Time RT-PCR in 
respiratory differential diagnosis, by the National Influenza Surveillance 
Network, sponsored by Brazilian Ministry of Health.
In addition, fast, accurate and sensitive detection of respiratory viruses 
in clinical specimens through the use of this methodology would also 
increase our understanding of the epidemiology of both new emerging 
viruses such as influenza A (H1N1) pdm09, and conventional viruses 
such as the common cold viruses, including rhinovirus and coronavirus.
Taking into account the development of vaccines and antiviral drugs, 
successful measures of prevention and control of the disease can be 
warranted as soon as the etiology of the disease is revealed.
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